4C Medical Technologies is a medical device company that develops minimally invasive therapies for structural heart disease.
4C Medical Technologies has raised $175.0M in total funding. The most recent round was Series D. The last funding was announced in March 2025.
4C Medical Technologies's investors include Boston Scientific, MicroPort CardioFlow, Anges Quebec, Yonghua Capital, Fu Yuan Investment.
4C Medical Technologies is headquartered in Maple Grove, United States.
4C Medical Technologies is a medical device company that develops minimally invasive therapies for structural heart disease.
4C Medical Technologies is at the Series D stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"4C Medical Technologies — Funding & Investors." VCBacked, March 5, 2025, https://www.vcbacked.co/company/4c-medical-technologies. Accessed November 15, 2026.
VCBacked. (2025). 4C Medical Technologies — Funding & Investors. Retrieved November 15, 2026, from https://www.vcbacked.co/company/4c-medical-technologies
{{cite web |title=4C Medical Technologies — Funding & Investors |url=https://www.vcbacked.co/company/4c-medical-technologies |website=VCBacked |access-date=November 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at 4C Medical Technologies? Request a listing update